Investigating NMJ Defects in SMA Following Central and Peripheral SMN Restoration
Completed
Conditions studied: Spinal Muscular Atrophy
In brief
This is an observational study to investigate the improvement of NMJ defects in adult patients with SMA following treatment with Risdiplam. Eligible patients will have received treatment with daily oral Risdiplam after receiving approval through their commercial insurance or drug assistance program. All subjects will be evaluated at one visit. Eligible subjects must have been receiving risdiplam for at least 12 months.
Key facts
- Study ID
- NCT05219487
- Run by
- Bakri Elsheikh
- People needed
- 18
- Starts
- 2021-10-13
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2026-02-23
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Signed Informed Consent Form
- Age 18-70 years at time of signing Informed Consent Form
- Able and willing to provide written informed consent and to comply with the program protocol according to ICH and local regulations
- Ability to comply with the study protocol, in the investigator's judgment
- Adequately recovered from any acute illness at the time of screening, and considered clinically well enough to participate, in the opinion of the treating physician
- Patients with retinopathy of prematurity should have evidence of stable disease
- Genetic confirmation of 5q SMA documented on standard genetic tests for the disorder
- Treated with risdiplam for a duration of 12 months or longer
You may not qualify if…
- Treatment with an investigational therapy within 180 days prior to initiation of study drug
- History of established diagnosis of neuromuscular junction disorder
- Co-morbid conditions that preclude travel or testing
- Patients who are, in the investigator's opinion, mentally or legally incapacitated to provide an informed consent
Where it is running
- The Ohio State University Wexner Medical Center — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.